Epstein Barr Virus (EBV), Quantitative PCR, Plasma (Southeast Michigan Only)
EBV DNA, EBV DNA PCR, EBV viral load, Epstein-Barr Virus, PTLD
Test Codes
EPIC: LAB1231712, Beaker: XEBVQNT, Viracor: 4501
Department
Send Outs
Specimen Collection Criteria
Collect: One Lavender-top EDTA tube.
Physician Office/Draw Specimen Preparation
Centrifuge to separate plasma from cells. Transfer plasma to a plastic transport tube at room temp (20-26°C or 68-78.8°F). (Minimum: 0.8 mL)
Preparation for Courier Transport
Transport: 2.0 mL plasma at room temp (20-26°C or 68-78.8°F). (Minimum: 0.8 mL)
Rejection Criteria
Specimens not collected and processed as indicated.
In-Lab Processing
Centrifuge to separate plasma from cells. Transfer plasma to a plastic transport tube at room temp (20-26°C or 68-78.8°F) immediately. (Minimum: 0.8 mL)
Storage
Specimen Stability for Testing:
All Specimen Types
Room temperature (20-26°C or 68-78.8°F): 4 days
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): 30 days
Specimen Storage in Department Prior to Disposal:
Specimen retention time is determined by the policy of the reference laboratory. Contact the Send Outs Laboratory with any questions.
Laboratory
Sent to Eurofins/Viracor in Lenexa, KS.
Performed
Monday – Saturday.
Results available in 1-3 days.
Reference Range
By report.
Test Methodology
Real-Time Polymerase Chain Reaction (PCR).
Interpretation
By report.
Clinical Disease
Epstein-Barr virus (EBV) is the etiological agent of infectious mononucleosis and has been implicated in African Burkitt's lymphoma and nasopharyngeal carcinoma. Childhood infections may be asymptomatic or produce "flu-like" illness. Adolescents and adults who escape infection during childhood experience infectious mononucleosis (IM). IM is characterized by irregular fever, pharyngitis, and lymphadenopathy lasting 1 to 4 weeks. Hematological abnormalities include an absolute increase in lymphocytes and monocytes exceeding 50% and more than 15% atypical lymphocytes, lasting for at least 2 weeks. Liver function tests generally reveal a mild to moderate increase in SPGT, SGOT, bilirubin, and LDH levels. IM is usually a benign and self-limited disease. Complications including splenomegaly and splenic rupture, hepatitis, pericarditis, myocarditis, or central nervous system involvement (Guillain-Barre syndrome, Bell's palsy, transverse myelitis, and meningoencephalitis) may occur following IM infection. (1)
Epidemiology
EBV occurs throughout the world and more than 90% of adults have antibodies to the virus. Most individuals acquire EBV early in life. Seroepidemiologic studies have indicated that 50% of children have antibodies to the virus by the time they are 5 years of age. No seasonality has been demonstrated. (1)
Incubation Period
The incubation period is 4-7 weeks. (1)
Transmission
EBV is poorly contagious. Transmission is via salivary contact, either through kissing or by exposure to contaminated eating implements. (1)
Reference
- Wiedbrauk D, Johnston SLG. Manual of Clinical Virology, Raven Press, New York,NY, 1993.
CPT Codes
87799
Contacts
Send Outs Laboratory – RO
248-551-9045
Name: Send Outs Laboratory – RO
Location:
Phone: 248-551-9045
Last Updated
10/24/2024
Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.